Syntab Therapeutics
About Syntab Therapeutics
Syntab Therapeutics, founded in October 2010, researches and develops innovative active ingredients using the company's proprietary platform for the production of synthetic antibodies. In early 2011, the company received funding for the synthetic antibody concept from the German Federal Ministry of Education and Research as part of the KMU-innovativ program.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Facts about Syntab Therapeutics
Facts about Syntab Therapeutics
- Focus : Manufacturer
- Industry : Pharma
